机译:The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice
Department of Clinical Cancer Prevention The University of Texas MD Anderson Cancer Center;
Department of Oncology The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Johns Hopkins;
Department of Medical Oncology Dana-Farber Cancer InstituteDepartment of Translational Molecular Pathology Sheikh Ahmed Center for Pancreatic Cancer ResearchClinical Cancer Genetics Program The University of Texas MD Anderson Cancer Center;
Cancer screening; Genetic testing; Germline mutations; Immunotherapy; Multigene panel testing; Pancreatic ductal adenocarcinoma; PARP inhibitors;